Arachidonic acid metabolites and endothelial dysfunction of portal hypertension

Prostaglandins and Other Lipid Mediators

Volumn 120, Issue , 2015, Pages 80-90

  Sacerdoti, David ^a   Pesce, Paola ^a   Di Pascoli, Marco ^a   Brocco, Silvia ^a   Cecchetto, Lara ^a   Bolognesi, Massimo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Keywords Arachidonic acid Portal hypertension Liver cirrhosis Prostaglandins Cyclooxygenase Leukotrienes Lipoxygenase EET 20 HETE Cytochrome P450 Epoxygenase Monooxygenase

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; HEME OXYGENASE 1; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2; VASCULOTROPIN;

ANGIOGENESIS; ARACHIDONIC ACID METABOLISM; ARTERIAL CIRCULATION; ARTICLE; COLLATERAL CIRCULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; LIVER REGENERATION; PERIPHERAL CIRCULATION; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PROTEIN EXPRESSION; PROTEIN FUNCTION; VASODILATATION; ANIMAL; BLOOD VESSEL; CIRCULATION; FEMALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ARACHIDONIC ACID; BLOOD CIRCULATION; BLOOD VESSELS; ENDOTHELIAL CELLS; FEMALE; HYPERTENSION, PORTAL;

EID: 84941811774     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2015.05.008     Document Type: Review

References (142)

1. J.N. Benoit, W.A. Womack, L. Hernandez, and D.N. Granger "Forward" and "backward" flow mechanisms of portal hypertension. Relative contributions in the rat model of portal vein stenosis Gastroenterology 89 November (5) 1985 1092 1096
2. J.G. Geraghty, W.J. Anderson, and D.C. Carter Portal venous pressure and portosystemic shunt in experimental portal hypertension Am J Physiol 257 1989 652 657
3. D. Lebrec, and R. Moreau Pathophysiology of portal hypertension Hepatogastroenterology 46 Suppl. 2 1999 1426 1428
4. E. Sikuler, and R.J. Groszmann Hemodynamic studies in long- and short-term portal hypertensive rats: the relationship to systemic glucagon levels Hepatology 6 1986 414 418
5. E. Sikuler, D. Kravetz, and R.J. Groszmann Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model Am J Physiol 248 1985 G618 G625
6. D.B. Cowan, and B.L. Langille Cellular and molecular biology of vascular remodelling Curr Opin Lipidol 7 1999 94 100
7. M. Papadaki, and S.G. Eskin Effects of fluid shear stress on gene regulation of vascular cells Biotechnol Prog 13 1997 209 221
8. M. Takahashi, T. Ishida, O. Traub, and M.A. Berk Mechanotransduction in endothelial cells: temporal signaling events in response to shear stress J Vasc Res 34 1997 212 219
9. B. Williams Mechanical influences on vascular smooth muscle cell function J Hypertens 16 1998 1921 1929
10. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
11. R.S. McCuskey Morphological mechanisms for regulating blood flow through hepatic sinusoids Liver 20 February (1) 2000 3 7
12. W.C. Arid Phenotypic heterogeneity of the endothelium: II. Representative vascular beds Circ Res 100 February (2) 2007 174 190
13. Y. Iwakiri Endothelial dysfunction in the regulation of portal hypertension Liver Int 32 February (2) 2012 199 213
14. M.K. Connolly, A.S. Bedrosian, A. Malhotra, and et al. In hepatic fibrosis, liver sinusoidal endothelial cells acquire enhanced immunogenicity J Immunol 185 4 2010 2200 2208
15. L. Tang, J. Yang, W. Liu, and et al. Liver sinusoidal endothelial cell lectin, LSECtin, negatively regulates hepatic T-cell immune response Gastroenterology 137 4 2009 1498 1508 e1-e5
16. R. Cheluvappa, G.M. Denning, G.W. Lau, M.C. Grimm, S.N. Hilmer, and D.G. Le Couteur Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells Int J Infect Dis 14 10 2010 e857 e867
17. P.S. Bhathal, and H.J. Grossman Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators J Hepatol 1 4 1985 325 337
18. T.K. Gupta, M. Toruner, M.K. Chung, and R.J. Groszmann Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats Hepatology 28 4 1998 Oct 926 931
19. C. Merkel, D. Sacerdoti, M. Bolognesi, and et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone Hepatology 26 1 1997 Jul 34 39
20. A.J. Elliot, L.T. Vo, V.L. Grossman, P.S. Bhathal, and H.J. Grossman Endothelin induced vasoconstriction in isolated perfused liver preparations from normal and cirrhotic rats J Gastroenterol Hepatol 12 1997 314 318
21. H.J. Grossman, V.L. Grossman, and P.S. Bhathal Enhanced vasoconstrictor response of the isolated perfused cirrhotic rat liver to humoral vasoconstrictor substances found in portal venous blood J Gastroenterol Hepatol 7 1992 283 287
22. M. Graupera, J.C. García-Pagán, E. Titos, and et al. 5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: A possible role of cysteinyl-leukotrienes Gastroenterology 119 February 2000 794 805
23. B.S. Ding, D.J. Nolan, J.M. Butler, and et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration Nature 468 7321 2010 310 315
24. D. Thabut, and V. Shah Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J Hepatol 53 5 2010 976 980
25. M. Hernandez-Guerra, J.C. Garcia-Pagan, J. Turnes, and et al. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension Hepatology 43 3 2006 485 491
26. H. García-Calderó, A. Rodríguez-Vilarrupla, J. Gracia-Sancho, and et al. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats J Hepatol 54 April (4) 2011 660 665
27. J. Bosch Vascular deterioration in cirrhosis: the big picture J Clin Gastroenterol 41 Suppl. 3 2007 S247 S253
28. Y. Iwakiri, and R.J. Groszmann The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule Hepatology 43 Suppl. 1(2) 2006 S121 S131
29. M. Graupera, S. March, P. Engel, J. Rodés, J. Bosch, and J.C. García-Pagán Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers Am J Physiol Gastrointest Liver Physiol 288 April (4) 2005 G763 G770
30. N.A. Mohammed, S.A. El-Aleem, H.A. El-Hafiz, and R.F.T. McMahon Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis J Clin Pathol 57 2004 350 354
31. M. Graupera, J.C. Garcia-Pagan, J.G. Abraldes, and et al. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers Hepatology 37 2003 172 181
32. T. Ge, H. Hughes, D.C. Junquero, K.K. Wu, P.M. Vanhoutte, and C.M. Boulanger Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta Circ Res 76 1995 1003 1010
33. D. Fu-Xiang, M. Jameson, J. Skopec, A. Diederich, and D. Diederich Endothelial dysfunction of resistance arteries of spontaneously hypertensive rats J Cardiovasc Pharmacol 20 Suppl. 12 1992 S190 S192
34. W.G. Mayhan Role of prostaglandin H2-thromboxane A2 in responses of cerebral arterioles during chronic hypertension Am J Physiol 262 1992 H539 H543
35. M. Graupera, J.C. García-Pagán, M. Parés, and et al. Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers J Hepatol 39 October (4) 2003 515 521
36. M. Graupera, J.C. García-Pagán, J.G. Abraldes, and et al. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers Hepatology 37 January (1) 2003 172 181
37. J. Garcia-Sancho, B. Laviña, A. Rodríguez-Vilarrupla, H. García-Calderó, J. Bosch, and J.C. García-Pagán Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers J Hepatol 47 August (2) 2007 220 227
38. E. Rosado, A. Rodríguez-Vilarrupla, J. Gracia-Sancho, M. Monclús, J. Bosch, and J.C. García-Pagán Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats J Cell Mol Med 16 October (10) 2012 2461 2470
39. A. Rodríguez-Vilarrupla, B. Laviña, H. García-Calderó, and et al. PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats J Hepatol 56 May (5) 2012 1033 1039
40. M. Di Pascoli, M. Diví, A. Rodríguez-Vilarrupla, and et al. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats J Hepatol 58 May (5) 2013 904 910
41. E. Rosado, A. Rodríguez-Vilarrupla, J. Gracia-Sancho, and et al. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats Hepatology 58 October (4) 2013 1424 1435
42. J.Z. Haeggström, and C.D. Funk Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease Chem Rev 111 2011 5866 5898
43. I. Ivanov, D. Heydeck, K. Hofheinz, and et al. Molecular enzymology of lipoxygenases Arch Biochem Biophys 503 2010 161 174
44. P. Maderna, and C. Godson Lipoxins: resolutionary road Br J Pharm 158 2009 947 959
45. B. Samuelsson, S.E. Dahlen, J.A. Lindgren, C.A. Rouzer, and C.N. Serhan Leukotrienes and lipoxins: structures, biosynthesis, and biological effect Science 237 4819 1987 1171 1176
46. T.R. Jones, R. Zamboni, M. Belley, and et al. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist Can J Physiol Pharmacol 67 1 1989 17 28
47. D. Keppler Leukotrienes: biosynthesis, transport, inactivation and analysis Rev Physiol Biochem Pharmacol 121 1992 1 30
48. D. Keppler, and J. Konig Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in the liver FASEB J 11 1997 509 516
49. E. Titos, J. Clària, R.N. Bataller, and et al. Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis Gastroenterology 119 September (3) 2000 794 805
50. C.J. Steib, M. Bilzer, M. op den Winkel, and et al. Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis Hepatology 51 June (6) 2010 2086 2096
51. Y. Kanaoka, and J.A. Boyce Cysteinyl leukotrienes and their receptors J Immunol 173 2004 1503 1510
52. A.R. Villarupla, M. Fernandez, J. Bosh, and J.C. Garcia Pagan Current concepts on the pathophysiology of portal hypertension Ann Hepatol 6 1 2007 28 36
53. H. Reynaert, M.G. Thompson, T. Thomas, and A. Geerts Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension Gut 50 2002 571 581
54. S.J. Feinmark, and P.J. Cannon Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes J Biol Chem 261 1986 16466 16472
55. H. Liu, Y. Gor, and S.J. Feinmark Regulation of leukotriene A4 hydrolase activity in endothelial cells by phosphorylation, Rybina IV1 J Biol Chem 272 50 1997 Dec 12 31865 31871
56. Y. Ishii, S.K. Lo, and A.B. Malik Neutrophil adhesion to TNF alpha-activated endothelial cells potentiates leukotriene B4 production J Cell Physiol 153 October (1) 1992 187 195
57. S.J. Feinmark The role of the endothelial cell in leukotriene biosynthesis Am Rev Respir Dis 146 November (5 Pt 2) 1992 S51 S55
58. B.O. Ibe, and W.B. Campbell Synthesis and metabolism of leukotrienes by human endothelial cells: influence on prostacyclin release Biochim Biophys Acta 960 June (3) 1988 309 321
59. E. Mark, Brezinski, A. Michael, K.C. Gimbrone Jr., Nicolaou, and C.N. Serhan Lipoxins stimulate prostacyclin generation by human endothelial cells FEBS Lett 245 March (1,2) 1989 167 172
60. Duah E, Adapala RK, Al-Azzam N, et al. Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT2 and CysLT1 receptors, Sci Rep 2013;3(November) Article number: 3274.
61. X.Y. Hua, S.E. Dahlén, J.M. Lundberg, S. Hammarström, and P. Hedqvist Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig Arch Pharmacol 330 August (2) 1985 136 141
62. G. Mehta, T. Gustot, R.P. Mookerjee, and et al. Inflammation and portal hypertension. The undiscovered country J Hepatol 61 2014 155 163
63. T. Yokomizo, K. Kato, K. Terawaki, T. Izumi, and T. Shimizu A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders J Exp Med 192 2000 421 432
64. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 January (1) 2002 131 185
65. D. Sacerdoti, A. Gatta, and J.C. McGiff Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology Prostaglandins Other Lipid Med 72 October (1-2) 2003 51 71
66. D. Sacerdoti, B. Escalante, N.G. Abraham, J.C. McGiff, R.D. Levere, and M.L. Schwartzman Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats Science 243 January (4889) 1989 388 390
67. L.D. Orozco, H. Liu, E. Perkins, and et al. 20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries J Pharmacol Exp Ther 346 July (1) 2013 67 74
68. C.C. Wu, T. Gupta, V. Garcia, Y. Ding, and M.L. Schwartzman 20-HETE and blood pressure regulation: clinical implications Cardiol Rev 22 January-February (1) 2014 1 12
69. J.C. Frisbee, R.J. Roman, J.R. Falck, J.R. Linderman, and J.H. Lombard Impairment of flow-induced dilation of skeletal muscle arterioles with elevated oxygen in normotensive and hypertensive rats Microvasc Res 60 July (1) 2000 37 48
70. C.L. Oltman, N.L. Weintraub, M. VanRollins, and K.C. Dellsperger Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation Circ Res 83 November (9) 1998 932 939
71. D. Sacerdoti, H. Jiang, S. Gaiani, J.C. McGiff, A. Gatta, and M. Bolognesi 11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension Prostaglandins Other Lipid Med 96 November (1-4) 2011 72 75
72. A.E. Loot, and I. Fleming Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential C6 channels J Cardiovasc Pharmacol 57 2011 140 147
73. 11,12-EET stimulates the association of BK channel α and ß1 subunits in mitochondria to induce pulmonary vasoconstriction. PLoS ONE 2012;7:1-8.
74. D. Sacerdoti, D. Mania, H. Jiang, and et al. Increased EETs participate in peripheral endothelial dysfunction of cirrhosis Prostaglandins Other Lipid Med 98 August (3-4) 2012 129 132
75. A.M. Rappaport, P.J. MacPhee, M.M. Fisher, and M.J. Phillips The scarring of the liver acini (Cirrhosis). Tridimensional and microcirculatory considerations Virchows Arch 402 1983 107 137
76. K. Taura, S. De Minicis, E. Seki, and et al. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis Gastroenterology 135 2008 1729 1738
77. E. Novo, S. Cannito, E. Zamara, and et al. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells Am J Pathol 170 2007 1942 1953
78. I. Fleming Vascular cytochrome p450 enzymes: physiology and pathophysiology Trends Cardiovasc Med 18 1 2008 20 25
79. B.S. Ding, and et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization Cell 147 October (3) 2011 539 553
80. D. Panigrahy, B.T. Kalish, S. Huang, and et al. Epoxyeicosanoids promote organ and tissue regeneration Proc Natl Acad Sci USA 110 August (33) 2013 13528 13533
81. M. Morales-Ruiz, and W. Jimenez Neovascularization, angiogenesis, and vascular remodeling in portal hypertension 2005 Humana Press Totowa, NJ
82. D.A. Langer, and V.H. Shah Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis J Hepatol 44 1 2006 209 216
83. D.E. Newby, and P.C. Hayes Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal' QJM 95 December (12) 2002 827 830
84. J.G. Abraldes, Y. Iwakiri, M. Loureiro-Silva, and et al. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state Am J Physiol Gastrointest Liver Physiol 290 2006 G980 G987
85. Y. Iwakiri, and R.J. Groszmann Vascular endothelial dysfunction in cirrhosis J Hepatol 46 5 2007 927 934
86. Y. Iwakiri The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension J Clin Gastroenterol 41 Suppl. 3(10) 2007 S288 S294
87. E.F. Grabowski, B.B. Weksler, and E.A. Jaffe Prostacyclin production by cultured endothelial cell monolayers exposed to step increases in shear stress J Lab Clin Med 105 1985 36 43
88. S.L. Hong, and D. Deykin Activation of phospholipase A2 and C in pig aortic endothelial cells synthesizing prostacyclin J Biol Chem 257 1982 7151 7154
89. L.J. Marnett, S.W. Rowlinson, D.C. Goodwin, A.S. Kalgutkar, and C.A. Lanzo Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition J Biol Chem 274 1999 22903 22906
90. J.N. Topper, J. Cai, D. Falb, and M.A. Gimbrone Jr. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress Proc Natl Acad Sci USA 93 September (19) 1996 10417 10422
91. J.N. Topper, and M.A. Gimbrone Jr. Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype Mol Med Today 5 1999 40 46
92. J.Y. Jeremy, D.P. Mikhailidis, S. Karatapanis, and et al. Altered prostacyclin synthesis by aortae from hepatic portal vein-constricted rats: evidence for effects on protein kinase C and calcium J Hepatol 21 1994 1017 1022
93. M. Ohta, F. Kishihara, M. Hashizume, and et al. Increased prostacyclin content in gastric mucosa of cirrhotic patients with portal hypertensive gastropathy Prostaglandins Leukot Essent Fatty Acids 53 1995 41 45
94. J.V. Sitzmann, K. Campbell, Y. Wu, and C. St. Clair Prostacyclin production in acute, chronic, and long-term experimental portal hypertension Surgery 115 1994 290 294
95. J. Yin, X. Leng, and J. Zhu Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication Chung Hua Wai Ko Tsa Chih 33 1995 563 565
96. M.C. Hou, P.A. Cahill, S. Zhang, and et al. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation Hepatology 27 1998 20 27
97. M. Fernandez, J.C. Garcia-Pagan, M. Casadevall, and et al. Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis Gastroenterology 110 1996 1529 1535
98. C.C. Chan, F.Y. Lee, S.S. Wang, and et al. Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin Hepatology 30 1999 630 635
99. C. Guarner, and G. Soriano Prostaglandin and portal hypertension Prostaglandins Leukot Essent Fatty Acids 48 1993 203 206
100. F. Oberti, P. Sogni, S. Cailmail, R. Moreau, B. Pipy, and D. Lebrec Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension Hepatology 18 1993 621 627
101. Y. Wu, R.C. Burns, and J.V. Sitzmann Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension Hepatology 18 1993 1416 1421
102. A. Munoz, J. Albillos, M. Perez-Paramo, I. Rossi, and M. Alvarez-Mon Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats Am J Physiol 276 1999 G687 G693
103. A. Bouaziz, M.M. de Ficquelmont-Loizos, A. Richert, and A. Caprani Direct physical factors and PGI2 and TXA2 secretions by a human endothelial cell line: in vitro investigation of pressure and shear stress applied independently or in synergy Thromb Res 90 1998 279 289
104. K. Okahara, B. Sun, and J. Kambayashi Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells Arterioscler Thromb Vasc Biol 18 1998 1922 1926
105. R.J. Segurola Jr., B. Oluwole, I. Mills, and et al. Cyclic strain is a weak inducer of prostacyclin synthase expression in bovine aortic endothelial cells J Surg Res 69 1997 135 138
106. K. Tsugawa, M. Hashizume, S. Migou, and et al. A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal ypertension without inducing gastric mucosal injury J Gastroenterol Hepatol 14 1999 642 651
107. R.J. Hendrickson, C. Cappadona, E. Yankah, J.V. Sitzmann, P.A. Cahill, and E.M. Redmond Sustained pulsatile flow regulates endothelial nitric oxide synthase and cyclooxygenase expression in co-cultured vascular endothelial and smooth muscle cells J Mol Cell Cardiol 31 1999 619 629
108. Lefebvre Blandine, Caron Françoise, Bessard Germain, Stanke-Labesque. Effect of 5-lipoxygenase blockade on blood pressure and acetylcholine-evoked endothelium-dependent contraction in aorta from spontaneously hypertensive rats. Françoise J Hypertens January 2006;24-1:85-93.
109. E.E. Gordon, J.A. Gordon, and A.A. Spector HETEs and coronary artery endothelial cells: metabolic and functional interactions Am J Physiol Cell Physiol 261 4 1991 C623 C633
110. K. Lötzer, C.D. Funk, and A.J. Habenicht The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis Biochim Biophys Acta 1736 September (1) 2005 30 37
111. A.W. Miller, P.V.G. Katakam, H.C. Lee, C.D. Tulbert, D.W. Busija, and N.L. Weintraub Arachidonic acid-induced vasodilation of rat small mesenteric arteries is lipoxygenase-dependent J Pharmacol Exp Ther 304 2003 139 144
112. M.H. Zink, C.L. Oltman, T. Lu, and et al. 12-Lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation Am J Physiol Heart Circ Physiol 280 2001 H693 H704
113. S.L. Pfister, N. Spitzbarth, K. Nithipatikom, W.S. Edgemond, J.R. Falck, and W.B. Campbell Identification of 11,14,15- and 11,12,15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta J Biol Chem 273 1998 30879 30887
114. P.A. Stapleton, A.G. Goodwill, M.E. James, and J.C. Frisbee Altered mechanisms of endothelium-dependent dilation in skeletal muscle arterioles with genetic hypercholesterolemia Am J Physiol Regul Integr Comp Physiol 293 2007 R1110 R1119
115. M. Félétou Calcium-activated potassium channels and endothelial dysfunction: therapeutic options? Br J Pharmacol 156 February (4) 2009 545 562
116. K.M. Gauthier, D.H. Goldman, N.T. Aggarwal, Y. Chawengsub, J.R. Falck, and W.B. Campbell Role of arachidonic acid lipoxygenase metabolites in acetylcholine-induced relaxations of mouse arteries Am J Physiol Heart Circ Physiol 300 March (3) 2011 H725 H735
117. Y. Chawengsub, K.M. Gauthier, and W.B. Campbell Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone Am J Physiol Heart Circ Physiol 297 August (2) 2009 H495 H507
118. W.B. Campbell, N. Spitzbarth, K.M. Gauthier, and S.L. Pfister 11,12,15 Trihydroxyeicosatrienoic acid mediates acetylcholine-induced relaxations in the rabbit aorta Am J Physiol Heart Circ Physiol 285 2003 H2648 H2656
119. W.B. Campbell, and K.M. Gauthier Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway J Cardiovasc Pharmacol 61 March (3) 2013 176 187
120. T. Kriska, C. Cepura, L. Siangjong, and et al. Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts Prostaglandins Other Lipid Med 106 October 2013 8 15
121. N.T. Aggarwal, Y. Chawengsub, K.M. Gauthier, H. Viita, S. Yla-Herttuala, and W.B. Campbell Endothelial 15-lipoxygenase-1 overexpression increases acetylcholine-induced hypotension and vasorelaxation in rabbits Hypertension 51 February (2) 2008 246 251
122. M. Bolognesi, F. Zampieri, M. Di Pascoli, and et al. Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats Liver Int 31 2011 881 890
123. 2+ during acetylcholine-induced dilation of microvessels Br J Pharmacol 128 1999 124 134
124. Y. Nishikawa, D.W. Stepp, and W.M. Chilian In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation Am J Physiol 277 1999 H1252 H1259
125. C.J. Garland, F. Plane, B.K. Kemp, and T.M. Cocks Endothelium-dependent hyperpolarization: a role in the control of vascular tone Trends Pharmacol Sci 16 January (1) 1995 23 30
126. W.B. Campbell, and I. Fleming Epoxyeicosatrienoic acids and endothelium-dependent responses Pflugers Arch 459 2010 881 895
127. I.R. Hutcheson, A.T. Chaytor, W.H. Evans, and T.M. Griffith Nitric oxide-independent relaxations to acetylcholine and A23187 involve different routes of heterocellular communication. Role of Gap junctions and phospholipase A2 Circ Res 84 1999 53 63
128. H.J. Taylor, A.T. Chaytor, W.H. Evans, and T.M. Griffith Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18-alpha glycyrrhetinic acid Br J Pharmacol 125 1998 1 3
129. Y. Takamura, H. Shimokawa, H. Zhao, H. Igarashi, K. Egashira, and A. Takeshita Important role of endothelium-derived hyperpolarizing factor in shear stress-induced endothelium-dependent relaxations in the rat mesenteric artery J Cardiovasc Pharmacol 34 1999 381 387
130. Garcia-Estan, N.M. Atucha, J.M. Sabio, F. Vargas, T. Quesada, and J.C. Romero Increased endothelium-dependent renal vasodilation in cirrhotic rats Am J Physiol 267 1994 R549 R553
131. A. Heinemann, and R.E. Stauber Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats J Hepatol 24 1996 739 746
132. R.T. Mathie, V. Ralevic, K.P. Moore, and G. Burnstock Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide? Hepatology 23 1996 130 136
133. D. Sacerdoti, C. Colombrita, M. Di Pascoli, and et al. 11,12-poxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells Prostaglandins Other Lipid Med 82 January (1-4) 2007 155 161
134. D. Sacerdoti, M. Bolognesi, M. Di Pascoli, and et al. Am J Physiol Heart Circ Physiol 291 October (4) 2006 H1999 H2002
135. M. Bolognesi, D. Sacerdoti, A. Piva, and et al. Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats J Pharmacol Exp Ther 321 April (1) 2007 187 194
136. C.C. Sieber, L.T. Sumanovski, M. Stumm, and et al. In vivo angiogenesis in normal and portal hypertensive rats: role of basic fibroblast growth factor and nitric oxide J Hepatol 34 2001 644 650
137. L.T. Sumanovski, E. Battegay, M. Stumm, and et al. Increased angiogenesis in portal hypertensive rats: role of nitric oxide Hepatology 29 1999 1044
138. H.C. Huang, O. Haq, T. Utsumi, and et al. Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressure J Cell Mol Med 16 2012 1125 1133
139. M. Fernandez, F. Vizzutti, J.C. Garcia-Pagan, and et al. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice Gastroenterology 126 2004 886 894
140. A.M. Geerts, A.S. De Vriese, E. Vanheule, and et al. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study Liver Int 26 2006 889 898
141. C. Van Steenkiste, A. Geerts, E. Vanheule, and et al. Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension Gastroenterology 137 2009 2112-24 e1-6
142. C. Van Steenkiste, B. Trachet, C. Casteleyn, and et al. Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodents Lab Invest 90 2010 1558 1572